US Stock MarketDetailed Quotes

IMUX Immunic

Watchlist
  • 1.260
  • +0.030+2.44%
Trading Apr 30 12:09 ET
113.50MMarket Cap-597P/E (TTM)

About Immunic Company

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm’s products include IMU-838, IMU-935, and IMU-856. The company is headquartered in New York, NY.

Company Profile

SymbolIMUX
Company NameImmunic
Listing DateApr 17, 2014
Issue Price12.00
Founded2003
CEODr. Daniel Vitt, PhD
MarketNASDAQ
Employees77
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1200 Avenue of the Americas,Suite 200
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-332-255-9818
Websitehttp://www.immunic-therapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Daniel Vitt, PhD
  • Director, Chief Executive Officer and President
  • 2.56M
  • Dr. Andreas Muehler
  • Chief Medical Officer
  • 1.46M
  • Glenn Whaley
  • Chief Financial Officer
  • 1.48M
  • Patrick Walsh
  • Chief Business Officer
  • --
  • Dr. Hella Kohlhof
  • Chief Scientific Officer
  • --
  • Dr. Duane D. Nash, M.D.
  • Executive Chairman of the Board
  • 1.07M
  • Richard Alan Rudick
  • Director
  • --
  • Dr. Jorg Neermann, PhD
  • Independent Director
  • 78.62K
  • Monika Maria Tornsen
  • Independent Director
  • 125.87K
  • Tamar D. Howson
  • Independent Director
  • 76.12K
  • Barclay A. Phillips
  • Lead Independent Director
  • 86.12K
  • Inderpal Singh
  • General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg